The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation

Biochemical and Biophysical Research Communications

Volumn 406, Issue 2, 2011, Pages 285-291

  Nishida, Tamotsu ^a   Yamada, Yoshiji ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Mdm2; P53; SENP3; SMT3IP1; SUMO; Ubiquitination

Indexed keywords

PROTEIN MDM2; PROTEIN P53; PROTEINASE; SMT3IP1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPEPTIDASES; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; SUMO-1 PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 79952445531     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.034     Document Type: Article

References (32)

1. Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
2. Levine A.J. p53, the cellular gatekeeper review for growth and division. Cell 1997, 88:323-331.
3. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420:25-27.
4. Roth J., Dobbelstein M., Freedman D.A., Shenk T., Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 1998, 2:554-564.
5. Harris S.L., Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899-2908.
6. Appella E., Anderson C.W. Post-translational modification and activation of p53 by genotoxic stresses. Eur. J. Biochem. 2001, 268:2764-2772.
7. Melchior F., Hengst L. SUMO-1 and p53. Cell Cycle 2002, 1:245-249.
8. Miyauchi Y., Yogosawa S., Honda R., Nishida T., Yasuda H. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 2002, 277:50131-50136.
9. Hay R.T. SUMO: a history of modification. Mol. Cell 2005, 18:1-12.
10. Geoffroy M.C., Hay R.T. An additional role for SUMO in ubiquitin-mediated proteolysis. Nat. Rev. Mol. Cell Biol. 2009, 10:564-568.
11. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends. Biochem. Sci. 2007, 32:286-295.
12. Hay R.T. SUMO-specific proteases: atwist in the tail. Trends. Cell Biol. 2007, 17:370-376.
13. Nishida T., Tanaka H., Yasuda H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 2000, 267:6423-6427.
14. Nishida T., Yamada Y. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin. Biochem. Biophys. Res. Commun. 2008, 374:382-387.
15. Borer R.A., Lehner C.F., Eppenberger H.M., Nigg E.A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390.
16. Boisvert F.M., van Koningsbruggen S., Navascués J., Lamond A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 2007, 8:574-585.
17. Grisendi S., Mecucci C., Falini B., Pandolfi P.P. Nucleophosmin and cancer. Nat. Rev. Cancer 2006, 6:493-505.
18. Tago K., Chiocca S., Sherr C.J. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc. Natl. Acad. Sci. USA 2005, 102:7689-7694.
19. Liu X., Liu Z., Jang S.W., Ma Z., Shinmura K., Kang S., Dong S., Chen J., Fukasawa K., Ye K. Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc. Natl. Acad. Sci. USA 2007, 104:9679-9684.
20. Kuo M.L., den Besten W., Thomas M.C., Sherr C.J. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Cell Cycle 2008, 7:3378-3387.
21. Haindl M., Harasim T., Eick D., Muller S. The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep. 2008, 9:273-279.
22. Yun C., Wang Y., Mukhopadhyay D., Backlund P., Kolli N., Yergey A., Wilkinson K.D., Dasso M. Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases. J. Cell Biol. 2008, 183:589-595.
23. Kurki S., Peltonen K., Latonen L., Kiviharju T.M., Ojala P.M., Meek D., Laiho M. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004, 5:465-475.
24. Colombo E., Marine J.C., Danovi D., Falini B., Pelicci P.G. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 2002, 4:529-533.
25. Nishida T., Terashima M., Fukami K., Yamada Y. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1. Biochem. J. 2007, 405:481-488.
26. Klibanov S.A., O'Hagan H.M., Ljungman M. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J. Cell Sci. 2001, 114:1867-1873.
27. Latonen L., Kurki S., Pitkänen K., Laiho M. p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. Cell. Signal. 2003, 15:95-102.
28. Ma J., Martin J.D., Zhang H., Auger K.R., Ho T.F., Kirkpatrick R.B., Grooms M.H., Johanson K.O., Tummino P.J., Copeland R.A., Lai Z. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. Biochemistry 2006, 45:9238-9245.
29. Chiu S.Y., Asai N., Costantini F., Hsu W. SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol. 2008, 6:e310.
30. M. Jiang, S.Y. Chiu, W. Hsu, SUMO-specific protease 2 in Mdm2-mediated regulation of p53, Cell Death. Differ. in press.
31. Lee M.H., Lee S.W., Lee E.J., Choi S.J., Chung S.S., Lee J.I., Cho J.M., Seol J.H., Baek S.H., Kim K.I., Chiba T., Tanaka K., Bang O.S., Chung C.H. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination. Nat. Cell Biol. 2006, 8:1424-1431.
32. Zhang Z., Zhang R. p53-independent activities of MDM2 and their relevance to cancer therapy. Curr. Cancer Drug Targets 2005, 5:9-20.